Thromboembolism: all 818 studies

Page 7 of 9. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.

• Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE StudiesCompletedNCT01715779
• Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee ArthroplastyCompletedNCT01713361Phase 2
• Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic DisorderCompletedNCT01707394Phase 1
• Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care TherapyCompletedNCT01619007
• Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer ResectionTerminatedNCT01608919Not applicable
• Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous ThromboembolismCompletedNCT01602445
• Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer PatientsWithdrawnNCT01602432
• Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlertsCompletedNCT01598805Not applicable
• Obstructive Sleep Apnea in Pulmonary EmbolismCompletedNCT01580085
• Incidence of Venous Thromboembolism Following Surgery in Patients With Colorectal CancerStatus unknownNCT01567917
• Fiix-prothrombin Time for Monitoring WarfarinCompletedNCT01565239Phase 2
• Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through PathwaysCompletedNCT01561885Not applicable
• Ultrasonography of Chest Versus Pulmonary Artery CT Angiography in Patients With Symptoms and Signs in Favor of PTEStatus unknownNCT01558206
• Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty.CompletedNCT01557725
• Evaluation of Contrast Medium Enhanced Post-mortem CT in Virtual AutopsyCompletedNCT01541995
• Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVDStatus unknownNCT01531829Phase 4
• Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)CompletedNCT01524653Phase 2
• Risk of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro FertilizationCompletedNCT01524393
• Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)WithdrawnNCT01523418
• Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture SurgeryStatus unknownNCT01509118
• ICU Venous Thromboembolism Incidence Study in a Chinese PopulationStatus unknownNCT01504087
• Pharmacogenetics of AcenocoumarolCompletedNCT01492777
• The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study)CompletedNCT01466426
• Effect of Tumescent Lidocaine on Platelet FunctionCompletedNCT01463280Phase 1
• Anticoagulant After Implantation of Biological Aortic Valve Comparing With AspirinCompletedNCT01452568Phase 4
• Optimal Prophylactic Method of Venous Thromboembolism (VTE)Status unknownNCT01448746Phase 3
• Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical PatientsWithdrawnNCT01446510
• Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty SurgeryCompletedNCT01431456Phase 3
• Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)CompletedNCT01428544
• Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism TreatmentCompletedNCT01428531
• Special Drug Use Investigation for ARIXTRA® (Fondaparinux) InjectionCompletedNCT01420809
• Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical PatientsCompletedNCT01401725Not applicable
• Institutional Registry of Thromboembolic DiseaseStatus unknownNCT01372514
• Clearance Of Mucus In Stents (COMIS)CompletedNCT01370278Not applicable
• National Inferior Vena Cava (IVC) Filter RegistryTerminatedNCT01367184
• CV Events in Emetogenic ChemotherapyCompletedNCT01366599
• Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese PatientsStatus unknownNCT01363193Not applicable
• Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)Status unknownNCT01357941
• Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K AntagonistCompletedNCT01348074Phase 2
• Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric CancerCompletedNCT01345773
• Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement SurgeryCompletedNCT01344954Phase 2
• Venous Thromboembolism Prophylaxis Post Cesarean SectionStatus unknownNCT01321788
• Subclinical Atherosclerosis Using Dual-source CT Coronary Angiography in Chinese Adults With Different Glycaemic StatusStatus unknownNCT01319201
• Ranibizumab and the Risk of Arterial Thromboembolic EventsTerminatedNCT01319188Phase 4
• Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal SurgeryCompletedNCT01308528Phase 3
• Improving Venous Thromboembolism ProphylaxisCompletedNCT01304108Phase 4
• Evaluation of the Prevention of Thromboembolic Disease in Patients With a Lower Limb Trauma, Non Surgical, in Winter Sports ResortCompletedNCT01303523
• Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in SwitzerlandCompletedNCT01277536
• The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic SurgeryCompletedNCT01267305Not applicable
• Graduated Compression Stockings (GCS) Pilot SubstudyCompletedNCT01234064Phase 3
• STA®-Liatest®D-Di-Exclusion of Venous ThromboembolismCompletedNCT01221805
• Prevention of Venous Thromboembolism Disease in Emergency DepartmentsCompletedNCT01212393
• Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thromboticsCompletedNCT01210755Phase 4
• Dose-confirmatory Bridging Study in Total Knee ReplacementCompletedNCT01206972Phase 3
• Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case PresentationCompletedNCT01206751
• Dose-confirmatory Bridging Study in Total Hip ReplacementCompletedNCT01205932Phase 3
• Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous CatheterTerminatedNCT01195727Phase 1
• Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005CompletedNCT01176305
• Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary EmbolismTerminatedNCT01164046Phase 3
• Prevalence and Risk Factors of Venous Thromboembolism in Hospitalized Pediatric PatientsCompletedNCT01140386
• Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving ChemotherapyCompletedNCT01132833
• Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in CancerCompletedNCT01130025Phase 3
• EUropean Pharmacogenetics of AntiCoagulant Therapy - WarfarinCompletedNCT01119300Phase 4
• EUropean Pharmacogenetics of AntiCoagulant Therapy - PhenprocoumonCompletedNCT01119274Phase 4
• EUropean Pharmacogenetics of AntiCoagulant Therapy - AcenocoumarolCompletedNCT01119261Phase 4
• Mortality Due to Malignancy in Patients With Idiopathic Venous ThromboembolismTerminatedNCT01088334
• Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary BypassStatus unknownNCT01072955Phase 3
• Efficacy And Safety Of Unfractionated Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary BypassStatus unknownNCT01072747Phase 3
• Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy OutcomeCompletedNCT01068795Not applicable
• Obstructive Sleep Apnea and Venous ThromboembolismTerminatedNCT01051297
• Venous Thromboembolism in Advanced Gastric Cancer PatientsCompletedNCT01047618
• Xarelto Regulatory Post-Marketing SurveillanceCompletedNCT01029743
• YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical IllnessCompletedNCT01028950Phase 3
• Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter AblationCompletedNCT01006876Phase 3
• Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVTCompletedNCT01006733Phase 3
• Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008Status unknownNCT00982514
• Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With CancerTerminatedNCT00981903Phase 2
• The Swiss Venous Thromboembolism Cohort 65+CompletedNCT00973596
• Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC)CompletedNCT00968929Phase 4
• Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous ThromboembolismCompletedNCT00967304Phase 4
• Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a VeinCompletedNCT00964275Not applicable
• DULCIS (D-dimer and ULtrasonography in Combination Italian Study)CompletedNCT00954395
• Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)CompletedNCT00951574Phase 3
• A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal SurgeryCompletedNCT00942435Phase 3
• Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower ExtremitiesCompletedNCT00937911Phase 3
• Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous ThromboembolismCompletedNCT00937820Phase 3
• Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical PatientsStatus unknownNCT00934167Phase 2/3
• Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal InsufficiencyTerminatedNCT00927602Phase 4
• Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) ScansStatus unknownNCT00925808
• Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement SurgeryCompletedNCT00917254Phase 2/3
• Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement SurgeryCompletedNCT00913120Phase 2/3
• Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical PatientsWithdrawnNCT00912483Phase 3
• SALTO - Epidemiological Study on Compliance and Treatment SatisfactionCompletedNCT00911001
• A Cohort Study With 100 Subjects Having a Primary Total Knee Replacement, Taking Pradax Post Discharge for Ten DaysWithdrawnNCT00868179Phase 4
• Venous Thromboembolism in Pregnancy StudyStatus unknownNCT00856076
• Discharge ALERT: Quality Improvement InitiativeCompletedNCT00853463Not applicable
• Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based DosingCompletedNCT00851864Phase 4
• ODiXahip - a Phase IIa Dose Escalating Proof of Principle TrialCompletedNCT00839826Phase 2
• Xarelto for VTE Prophylaxis After Hip or Knee ArthroplastyCompletedNCT00831714
• The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice SettingsCompletedNCT00830570

← Thromboembolism overview